This streamlined approach not only accelerates the drug discovery pipeline but also improves the overall success rate of identifying viable drug targets. The AI-Powered Target Identification Service ...

There is no denying that artificial intelligence (AI) has captured ... used in the Schrödinger Drug Discovery Group for identifying hits for a wide range of target product profiles (TPP), with ...

Researchers have uncovered a promising therapeutic target for adenoid cystic carcinoma (ACC), a rare cancer of the salivary ...

Biotech company Valo Health and AI healthcare firm nference have entered into a multi-year partnership to leverage AI and ...

Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

In late 2019, Insilico’s AI-driven drug-discovery platform PandaOmics discovered a target for fibrotic diseases that involve excessive scar tissue. It then used its generative AI platform ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced ... on application of biology, hit discovery, target discovery,” he said.

Learn how AI-driven TechBio is revolutionizing biotech in our exclusive interview with Bullfrog AI CEO Vin Singh.

During a health-focused event in New York on Tuesday, Google announced that it’s developing a collection of “open” AI models for drug discovery called TxGemma. The AI models, which Google ...

A Boston drug discovery company that uses AI has hit unicorn valuation. It uses transformer diffusion models, which its CEO ...